Table 4 Pre and post NQOL score
From: Ramelteon combined with an α1-blocker decreases nocturia in men with benign prostatic hyperplasia
Variables | Median (mean±SD) | P value | |
|---|---|---|---|
Pre | Post | ||
Q1 | 1 (1.1 ± 1.2) | 1 (1.5 ± 1.2) | 0.280 |
Q2 | 2 (1.6 ± 1.3) | 1 (1.1 ± 1.0) | 0.048* |
Q3 | 2 (1.3 ± 1.1) | 1 (1.1 ± 1.2) | 0.531 |
Q4 | 1 (1.1 ± 1.3) | 1 (1.0 ± 0.8) | 0.709 |
Q5 | 1 (1.6 ± 1.6) | 0 (0.9 ± 1.2) | 0.077 |
Q6 | 2 (2.2 ± 1.5) | 2 (1.7 ± 1.3) | 0.048* |
Q7 | 2 (2.2 ± 1.4) | 1 (1.6 ± 1.0) | 0.070 |
Q8 | 1 (0.7 ± 0.9) | 1 (1.1 ± 1.2) | 0.136 |
Q9 | 1 (1.5 ± 1.5) | 1 (1.4 ± 1.3) | 0.806 |
Q10 | 3 (2.2 ± 1.5) | 3 (2.3 ± 1.3) | 0.653 |
Q11 | 3 (2.3 ± 1.5) | 3 (2.4 ± 1.2) | 0.634 |
Q12 | 3 (2.3 ± 1.4) | 2 (2.1 ± 1.1) | 0.510 |
Q13 | 4 (4.5 ± 3.1) | 3 (4.1 ± 2.7) | 0.604 |
total score | 23 (24.7 ± 14.6) | 23 (22.4 ± 12.3) | 0.434 |